Herma F.
- Country
- The Netherlands
- Department
- afdeling Geriatrie en Ephor
Research Overview
- Safety, Tolerability, and Pharmacokinetics of Ent001 in Moderate to Severe Ulcerative Colitis Patients
- Phase 3b, Randomized, Open‑Label, Active‑Controlled Trial Comparing Guselkumab Versus Risankizumab for Efficacy and Safety in Moderately to Severely Active Crohn’s Disease
- Evaluation of Long-Term Safety and Efficacy of Upadacitinib in Patients with Ulcerative Colitis: A Phase 3 Multicenter Extension Study
Data & Insights
Has run more than one trial at 307 of 480 partner sites.
Specializations
Inflammatory Bowel Disease Management
This investigator specializes in treating complex inflammatory bowel disease (IBD), with particular emphasis on both Crohn's disease and ulcerative colitis. Their research encompasses innovative therapeutic approaches for patients with moderate to severe manifestations of these conditions.
- Moderate to Severe Crohn's Disease Treatment
- Ulcerative Colitis Therapy
- Novel Therapeutic Combinations
Their work involves evaluating cutting-edge treatments for IBD management.
Advanced Therapeutic Development
The investigator focuses on assessing targeted therapies and biological treatments for inflammatory bowel conditions. Their expertise includes evaluating both induction and maintenance therapy protocols for chronic gastrointestinal disorders.
- Monoclonal Antibody Treatments
- Combination Therapy Approaches
- Long-term Treatment Strategies
They contribute to developing therapeutic solutions for treatment-resistant cases.
Clinical Innovation
Their research encompasses novel pharmaceutical applications and treatment methodologies for inflammatory bowel conditions. The investigator evaluates both oral and subcutaneous treatment modalities for gastrointestinal disorders.
- Innovative Drug Delivery Systems
- Safety and Efficacy Assessment
- Treatment Response Evaluation
The focus includes investigating new therapeutic pathways for IBD treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.